::Company
::Partners
::Products
::Imagebank
::Facts
::Contact us
::Suomeksi

 

 

cholexit_banneri.gif

reducol_banneri.gif

Scanvit Ltd. and Forbes Medi-Tech Ltd. develop in cooperation fat free plant stanol and sterol tablets.

 

04.11.2003

Scanvit Ltd. and Forbes Medi-Tech Ltd. develop in cooperation fat free plant stanol and sterol tablets

Scanvit Ltd, a Finnish company focusing on the prevention of cardiovascular diseases and Forbes Medi-Tech Ltd. develop in cooperation fat free plant stanol and sterol tablets.
The active ingredient of the new product is plant stanol and sterol preparation, Reducol™. In numerous clinical trials plant stanols and sterols have been proven to effectively lower blood cholesterol level. Reducol™ is an internationally patented, researched and approved ingredient. Reducol™-trademark and patents are the property of Forbes Medi-Tech Inc.

More information

Scanvit Ltd.

info@scanvit.fi
www.scanvit.fi/en/

+358 9 6767 99

managing director

Perttu Rönkkö
perttu.ronkko@scanvit.fi

+358 50 537 2722

sales and marketing

Miku Santavirta
miku.santavirta@scanvit.fi

+385 400 4433 43


Latest news

» Cholesterol-lowering Pirkka Reducol range complemented by cheese slices


» Cholesterol-lowering Pirkka Reducol product range launched


» Cholexit offers a convenient way for self-treatment of high cholesterol.


» Scanvit Ltd and Tamro Finland / Pharmakon have made a marketing and distribution agreement.


» Scanvit Ltd. and Forbes Medi-Tech Ltd. develop in cooperation fat free plant stanol and sterol tablets.


  
Scanvit Oy Westendintie 1, 02160 Espoo, Finland, tel +358-9-6767 99, Fax +358-9-6768 99, info@scanvit.fi